Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06893484 · ClinicalTrials.gov registry record
Assessment of Early Pregnancy MAB Completion
A clinical trial of Pregnancy and Abortion Early, sponsored by University of Washington.
- Recruiting
- Registry status
- 400
- Enrollment target
- 3
- Study locations
NCT06893484: Recruiting study of Pregnancy and Abortion Early, sponsored by University of Washington.
NCT06893484 is a study of Pregnancy and Abortion Early that is actively recruiting participants, run by University of Washington. The registered enrollment target is 400 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06893484, a study of Pregnancy and Abortion Early, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Primary Outcome
To estimate the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 2 weeks after taking Mifepristone and compare this proportion to the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 4 weeks
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Weekly high-sensitivity urine pregnancy tests
Study Locations (3)
Georgia
- Carafem - Atlanta
Maryland
- Carafem - Chevy Chase
Washington
- Cedar River Clinics - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2026-04 |
What NCT06893484 shows while recruiting
NCT06893484 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Weekly high-sensitivity urine pregnancy tests is the first listed.
NCT06893484 reports a single indexed study location in Georgia, Maryland, Washington.
Frequently Asked Questions
What is clinical trial NCT06893484 about?
NCT06893484 is a clinical study titled "Assessment of Early Pregnancy MAB Completion". This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrol...
What is the current status of trial NCT06893484?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-03-13. Estimated completion is 2026-04.
What conditions does trial NCT06893484 study?
This clinical trial studies the following conditions: Pregnancy, Abortion Early.
What interventions are being tested in trial NCT06893484?
The interventions under investigation include: Weekly high-sensitivity urine pregnancy tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06893484?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06893484 being conducted?
This trial has 3 study locations across Georgia, Maryland, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06893484's enrollment target sits among peer trials
400 58th of 191 higher than 131 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI